Ede-Golightly James bought SLN
December 22, 2025 · Form 4 insider transaction
Ede-Golightly James bought 90,000 shares of Silence Therapeutics plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
90,000
Price
$0.00
Total value
N/A
InsiderEde-Golightly James
RoleDirector
SecurityShare Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 22, 2025
Filing dateDecember 22, 2025
Shares owned after90,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option shall vest in equal monthly installments over a one-year period measured from one month following December 22, 2025, subject to the Reporting Person's continuous service as of each applicable vesting date.